Match Document Document Title
10022431 Methods and materials for treating cancer  
This document provides methods and materials related to treating cancer. For example, methods and materials for using nucleic acid libraries to treat cancer are provided.
10022405 IL-12 immunotherapy for cancer  
Compositions and methods far delivering immune modulatory molecules to result in a therapeutic effect are disclosed. The compositions and methods use stably integrating lentiviral delivery...
10022402 Allogenic mesendritic vector for ovarian cancer  
A method of preparing an allogenic dendritic stem cell vaccine for treating ovarian cancers is disclosed. The method comprises, (a) collecting blood sample from an allogenic donor in a sterile...
10022390 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer  
Phosphoramidate derivates of 5-fluoro-2′-deoxyuridine are disclosed for use in the treatment of cancer, especially in the treatment of cancer where the patient shows resistance, for example, in a...
10022364 Methods of treating cancer patients with farnesyltransferase inhibitors  
The present invention relates to the field of molecular biology and cancer biology. Specifically, the present invention relates to methods of treating a subject with a farnesyltransferase...
10022356 Compounds for treatment of cancer  
The present invention relates to pharmaceutical compositions for treating cancer comprising BRAF inhibitors, (e.g. vemurafenib) and/or MEK inhibitor, (e.g. trametinib, RO5068760), in combination...
10022325 Compositions and methods for the treatment of cancer  
The present invention provides compositions and methods for the treatment of cancer are provided.
10018639 Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof  
The present invention relates to a method for the accurate, rapid and sensitive detection of breast or ovarian cancers from body fluid samples of a mammalian subject and related assay, kits and...
10018630 Cancer stem cell isolation  
An objective of the present invention is to provide: a cancer stem cell isolated using a cell marker; a substantively homogeneous cancer stem cell population including said cancer stem cell; and a...
10017579 Anti-cancer antibodies with reduced complement fixation  
The invention provides modified antibodies directed against GD2 that have diminished complement fixation relative to antibody-dependent, cell-mediated cytotoxicity, which is maintained. The...
10017578 Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies  
The invention generally relates to antibodies that bind to human folate receptor and diagnostic assays for folate receptor 1-based therapies. Methods of using the antibodies to monitor therapy are...
10017576 Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies  
The present invention provides a method for inducing a cancer specific immune response against MUC1 using an immunogenic glycopeptide. Other aspects of the invention are a pharmaceutical...
10017567 Treatment of cancer with anti-LAP monoclonal antibodies  
Described herein are compositions and methods relating to LAP-binding agents, including, for example, anti-LAP antibodies, and to their use in methods of treatment of cancer. LAP-binding agents...
10017564 Monoclonal antibodies against claudin-18 for treatment of cancer  
The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLD18, including tumor-related diseases such as gastric...
10017475 Anti-vasculature and anti-tubulin combretastatin analogs for treatment of cancer  
Combretastatins analog compounds and their pharmaceutically acceptable salts are presented, as well as pharmaceutical compositions comprising the combretastatin analog compounds and uses of the...
10016620 Tissue sampling and cancer treatment apparatus  
A catheter treatment apparatus comprises an elongate tubular member and an expandable support. The expandable support comprises a radioactive substance to treat cancerous tissue and is configured...
10016619 Systems and methods for treating cancer using brachytherapy  
Systems and methods are provided for treating cervical and/or uterine cancers in brachytherapy with an intracavitary brachytherapy applicator. The system comprises a tandem adapted for insertion...
10016519 18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer  
The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states of...
10016484 Methods of treating lung cancer  
Methods of treating cancers comprising FGFR1 gene amplification are provided. In some embodiments, the methods comprise administering a fibroblast growth factor receptor 1 (FGFR1) extracellular...
10016480 Peptide-based methods for treating pancreatic cancer  
Methods for treating a subject for pancreatic cancer via administration of small anti-inflammatory peptides are disclosed. The peptides may be administered in conjunction with another therapeutic...
10016470 Oncolytic adenoviruses for cancer treatment  
The invention relates to an oncolytic adenovirus for the treatment of cancer, containing a human DNA sequence isolating a promoter conferring selective expression on an adenoviral gene. Said...
10016468 Method and compositions for treating cancer using probiotics  
The subject invention pertains to probiotic compositions and methods of treating hepatocellular carcinoma (HCC) using the probiotic compositions. The probiotic compositions can inhibit growth of...
10016434 Methods for the treatment of HER2 amplified cancer  
Described herein are methods and compositions for treating HER2-amplified cancer. The methods include administering to an individual in need thereof ibrutinib.
10016398 Antimitotic amides for the treatment of cancer and proliferative disorders  
Novel, antimitotic heteroaryl amides and pharmaceutically acceptable salts of Formula I where Ar, R5, R6, R8, R9, R11, X1, and X2 are as defined herein, as compounds for treatment and prevention...
10016392 Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances  
A method for treating cancer is described using combination therapies comprising the use of hyperbaric oxygen with histone deacetylase inhibitors, with and without glycolytic therapies. The...
10016390 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Uses of duloxetine HCL medicament in preparing pharmaceutical treatment of cancer
 
Provided in the present invention are uses of duloxetine hydrochloride in preparing a pharmaceutical composition for treatment of cancer.
D822209 Cover for cancer cell observation camera  
D822208 Cover for cancer cell observation camera  
10013638 Cancer diagnostic method and system  
A method and system for classifying tissue suspected of being abnormal as being malignant or benign. The method includes generating a set of selection features, performing statistical applications...
10011877 Treatment of bladder cancer to overcome chemoresistance  
The disclosure demonstrates the correlation of the methylation status of the miR-193a gene and the expression level of the miR-193a-3p transcript with the resistance of bladder cancer cells to...
10011659 Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (TKI)  
Methods of treating a subject having cancer exhibiting a resistance to a tyrosine kinase inhibitor (TKI) are provided. Accordingly, there is provided a method comprising administering to the...
10011645 Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10011629 Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer  
The present invention is directed to compounds, compositions and methods for treating or preventing Flaviviridae family of viruses (including HCV, Yellow fever, Dengue, Chikungunya and West Nile...
10010719 Triple endorectal ballooning system for prostate cancer radiotherapy  
A triple endorectal ballooning (TERB) system for prostate cancer radiotherapy may include a first balloon unit, a second balloon unit, a third balloon unit, a central passageway and a cover. The...
10010618 Methods for treating cancer using combination therapies  
Described are methods, uses, and kits for utilizing a targeted ligand conjugate in combination with a thiol inhibitor or a system xc− inhibitor for the treatment of cancer or inflammation. Also...
10010608 Combination therapies for cancer  
A novel combination comprising a B-Raf inhibitor, particularly N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-th iazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a...
10010593 Recombinant Listeria vaccine strains and methods of using the same in cancer immunotherapy  
The present invention provides methods of treating, protecting against, and inducing an immune response against a human papillomavirus-associated oropharyngeal tumor or cancer, comprising the step...
10010561 Method of treating cancer using high efficiency self-illuminative nanocomplexes and method of manufacturing the same  
The present disclosure relates to a method of treating cancer using a composition including a target-specific self-illuminative nanocomplex which includes a self-illuminative nanocomplex including...
10010552 Combination therapy comprising a CDK4/6 inhibitor and a PI3K inhibitor for use in the treatment of cancer  
A combination of a CDK4/6 inhibitor and a P3Kinase inhibitor for the treatment of cancer.
10010542 PFKFB3 inhibit and methods of use as an anti-cancer therapeutic  
A novel compound, (E)-1-(pyridyn-4-yl)-3-(7-(trifluoromethyl)quinolin-2-yl)-pr op-2-en-1-one, is provided herein. (E)-1-(pyridyn-4-yl)-3-(7-(trifluoromethyl)quinolin-2-yl)-pr op-2-en-1-one is an...
10010520 Combined application of isothiocyanate compound and anti-cancer medicine  
The present invention relates to a combined application of isothiocyanate compounds and anti-cancer drugs, in particular to a composition, comprising: (A) a therapeutically effective amount of a...
10010504 Compositions and methods including celecoxib and plumbagin relating to treatment of cancer  
The present invention relates to compositions and methods for treatment of proliferative disease. In specific aspects, the present invention relates to compositions including celecoxib and...
10010277 Cancer detection by optical measurement of compression-induced transients  
A cancer screening method includes changing a compression state of selected tissue; and obtaining a signal indicative of a response of an optical property of the selected tissue in response to the...
RE46907 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulators  
Disclosed is a composition comprising a derivative of NDGA and at least one metabolic modulator. The composition can be in a unit dose form or kit. The composition can comprise at least two...
10006925 Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps  
Described herein are sets of metabolite and lipid (e.g., fatty acid) markers that can be used in the detection of early stage colorectal cancer and/or early development of adenomatous polyps....
10006092 Method to detect prostate cancer in a sample  
The present invention provides methods to detect prostate cancer by detecting the RNA encoded by PCA3. The disclosure provides a method for determining a predisposition, or presence of prostate...
10006091 Method for the diagnosis, prognosis and treatment of lung cancer metastasis  
The present invention relates to a method for the diagnosis or the prognosis of metastasis in lung cancer which comprises determining if the c-MAF gene is amplified in a primary tumor sample....
10006032 Predictive biomarker for cancer therapy  
The present invention relates generally to the identification of patients suffering from cancer whether they will respond to specific therapies. More particularly the invention relates to a method...
10006029 Methods of treating colorectal cancer  
Disclosed herein are methods for treating/and or preventing colorectal cancer using a specific inhibitor of SMAD7 expression or function. Also disclosed are pharmaceutical compositions containing...
10005765 Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer  
Provided herein are benzimidazole derivatives, for example, of Formula I, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or...